Brepocitinib (P-Tosylate) - HY-112708A
Nur noch %1 verfügbar
Catalog #
HY-112708A
Ab
39,00 €
Brepocitinib (PF-06700841) P-Tosylate is a potent dual Janus kinase 1 (JAK1) and TYK2 inhibitor with IC50s of 17 nM and 23 nM, respectively. Brepocitinib P-Tosylate also inhibits JAK2 and JAK3 with IC50s of 77 nM and 6.49 μM, respectively[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-112708A/Brepocitinib-P-Tosylate-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | COVID-19-immunoregulation |
| Alternative Names | PF-06700841 (P-Tosylate) |
| CAS | 2140301-96-6 |
| Storage | 4°C (Powder, sealed storage, away from moisture) |
| MWT | 561.60 |
| Solubility | DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 2 mg/mL (ultrasonic) |
| Clinical Information | Phase 3 |
| Target | JAK |
| Application: | COVID-19-immunoregulation |
|---|